SCHEMBL30837801

SCHEMBL30837801

COCCOc1cc(Cn2c(=O)c3cc(OCC(F)F)ccc3n(C3CCN(C=O)CC3)c2=O)ccc1OC

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 10/20 0.89
PDE7B Q9NP56 5/20 0.69
PDE8A O60658 3/20 0.69
OPRL1 P41146 2/20 0.34
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
KMT2A Q03164 2/20 0.34
TP53 P04637 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34
RXFP1 Q9HBX9 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
GAA P10253 1/20 0.33
MAPK1 P28482 1/20 0.33
DRD2 P14416 1/20 0.33
ADRA1D P25100 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL137082 1.00 PDE7A (0.89) PDE7APDE7BPDE8AOPRL1OPRM1
SCHEMBL100079 0.97 PDE7A (0.89) PDE7APDE7BPDE8AOPRL1OPRM1
SCHEMBL30837886 0.94 PDE7A (1.00) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100608 0.94 PDE7A (1.00) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL139050 0.94 PDE7A (0.87) PDE7APDE7BPDE8AOPRL1OPRM1
SCHEMBL100081 0.93 PDE7A (0.86) PDE7APDE7BPDE8AOPRL1OPRM1
SCHEMBL30837786 0.93 PDE7A (0.86) PDE7APDE7BPDE8AOPRL1OPRM1
SCHEMBL100673 0.93 PDE7A (0.91) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL30837950 0.93 PDE7A (0.91) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100080 0.92 PDE7A (0.95) PDE7APDE7BPDE8AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572765-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE Mitodicure GmbH (DE) 2025-06-25 EP disclosed
WO-2024038089-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE MITODICURE GMBH (DE) 2024-02-22 WO disclosed